GAME ON
agency: MicroMass Communications
brand: Fosrenol
client: Shire
photo from left: Jessica Brueggeman, senior behaviorist • Kim Levy, VP, strategic planning • Carl Malpass, VP, group account director • Bill Leinhos, director, dialysis clinics, Fosrenol, Shire • Jamie Cobb, executive creative director
When MicroMass was contracted to market Shire's Fosrenol, the drug, which lowers elevated blood phosphate levels, was third in its category. Rather than pelting overburdened docs with even more messages, the agency focused on an underleveraged audience in the space—patients.
The creative team developed a patient-education program using branded board games, cookbooks, crossword puzzles, and word searches, and made them available to patients receiving dialysis treatment at the clinics."For patients, the dialysis clinic is like a home away from home," says Jamie Cobb of MicroMass. "And so the whole idea of supporting each other and developing a community feel was a big underlying insight that fed into the creative."
The games were an innovative vehicle that enabled health-literate communications by keeping it simple—and at the same time, educating patients about this chronic and complicated disease.
PREVIOUS AGENCY ‹‹ HOME ›› NEXT AGENCY
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.